Microalbuminuria among type 1 and type 2 diabetic patients of African origin in Dar Es Salaam, Tanzania

BMC Nephrology

Volumn 8, Issue , 2007, Pages

  Lutale, Janet Joy Kachuchuru ^a,b   Thordarson, Hrafnkell ^d   Abbas, Zulfiqarali Gulam ^b,e   Vetvik, Kåre ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c Haraldsplass Deaconal Hospital   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e Abbas Medical Centre   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAZIDE DIURETIC AGENT; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICA; AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CHILD; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CREATININE BLOOD LEVEL; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SEX RATIO; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TANZANIA; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; ALBUMINURIA; COMORBIDITY; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; LINEAR MODELS; MALE; MIDDLE AGED; PREVALENCE; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TANZANIA; URINALYSIS;

EID: 33846474331     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-8-2     Document Type: Article

References (43)

1. Epidemiology, development and treatment of end-stage renal failure in type 2 (non-insulin-dependent) diabetic patients in Europe. AE Raine, Diabetologia 1993 36 1099 1104 10.1007/BF02374505 8243861
2. Nephropathy in type 2 diabetes. E Ritz, J Intern Med 1999 245 111 126 10.1046/j.1365-2796.1999.00411.x 10081514
3. Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota. DJ Ballard LL Humphrey LJ Melton 3rd PP Frohnert PC Chu WM O'Fallon PJ Palumbo, Diabetes 1988 37 405 412 3378684
4. Similar risks of nephropathy in patients with type I or type II diabetes mellitus. C Hasslacher E Ritz P Wahl C Michael, Nephrol Dial Transplant 1989 4 859 863 2515489
5. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. TJ Orchard JS Dorman RE Maser DJ Becker AL Drash D Ellis RE LaPorte LH Kuller, Diabetes 1990 39 1116 1124 2384191
6. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. HH Parving MA Gall P Skott HE Jorgensen H Lokkegaard F Jorgensen B Nielsen S Larsen, Kidney Int 1992 41 758 762 1513098
7. Diabetes in urban African-Americans. II. High prevalence of microalbuminuria and nephropathy in African-Americans with diabetes. MG Goldschmid WS Domin DC Ziemer DL Gallina LS Phillips, Diabetes Care 1995 18 955 961 7555556
8. Diabetic renal disease in African Americans. ED Crook, Am J Med Sci 2002 323 78 84 10.1097/00000441-200202000-00004 11863083
9. Prevalence and epidemiology of micro- and macroalbuminuria in Ethiopian diabetic patients. SI Rahlenbeck A Gebre-Yohannes, J Diabetes Complications 1997 11 343 349 10.1016/S1056-8727(96)00122-5 9365876
10. Microalbuminuria and retinopathy in a diabetic population of Cameroon. E Sobngwi JC Mbanya EN Moukouri KB Ngu, Diabetes Res Clin Pract 1999 44 191 196 10.1016/S0168-8227(99)00052-2 10462142
11. Microalbuminuria in non-insulin-dependent (type 2) Nigerian diabetics: relation to glycaemic control, blood pressure and retinopathy. RT Erasmus G Oyeyinka A Arije, Postgrad Med J 1992 68 638 642 1448404
12. Nephropathy in patients with recently diagnosed Type 2 diabetes mellitus in Black Africas. FW Wanjohi FCF Otieno EN Ogola EO and Amayo, East African Medical Journal 2002 79 399 404 12638839
13. Effect of metabolic factors and blood pressure on kidney function in proteinuric type 2 (non-insulin-dependent) diabetic patients. C Hasslacher A Bostedt-Kiesel HP Kempe P Wahl, Diabetologia 1993 36 1051 1056 10.1007/BF02374498 8243854
14. Microalbuminuria as a predictor of clinical diabetic nephropathy. CE Mogensen, Kidney Int 1987 31 673 689 3550239
15. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
16. International Society of Hypertension guidelines for the manegement of hypertension. WHO, J Hypertens 1999 17 151 183 10067786
17. Clinical summary report. Clinical performance of DCA 2000+ hemoglobin A1c system six-minute assay. CE Hiar, Bayer Diagnostic Division 1-7, April 1998
18. The Diabetes Research in Children Network (DirectNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirectNet) Study. Pediatric Diabetes 2005 6 13 16 10.1111/j.1399-543X. 2005.00088.x 15787896
19. Gault MH. Prediction of creatinine clearance from serum creatinine. Cockcroft DW, Nephron 1976 16 31 41 1244564
20. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. AS Levey J Coresh E Balk AT Kausz A Levin MW Steffes RJ Hogg RD Perrone J Lau G Eknoyan, Ann Intern Med 2003 139 137 147 12859163
21. Predictors of the development of microalbuminuria in patients with Type 1 diabetes mellitus: a seven-year prospective study. The Microalbuminuria Collaborative Study Group. Diabet Med 1999 16 918 925 10.1046/j.1464-5491.1999. 00182.x 10588521
22. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. J Cederholm B Eliasson PM Nilsson L Weiss S Gudbjornsdottir, Diabetes Res Clin Pract 2005 67 258 266 10.1016/j.diabres.2004.07.021 15713359
23. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes. SM Marshall KG Alberti, Q J Med 1989 70 61 71 2594949
24. Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. ER Mathiesen N Saurbrey E Hommel HH Parving, Diabetologia 1986 29 640 643 10.1007/BF00869263 3792697
25. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. G Bruno P Cavallo-Perin G Bargero M Borra V Calvi N D'Errico P Deambrogio G Pagano, Diabetes Care 1996 19 43 47 8720532
26. The prevalence of proteinuria detected by Albustix in a defined diabetic population. W Gatling MA Mullee RD Hill, Diabet Med 1988 5 256 260 2967147
27. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. MA Gall P Rossing P Skott P Damsbo A Vaag K Bech A Dejgaard M Lauritzen E Lauritzen P Hougaard, Diabetologia 1991 34 655 661 10.1007/BF00400995 1955098
28. Storage temperature and differing methods of sample preparation in the measurement of urinary albumin. AC Collins M Sethi FA MacDonald D Brown GC Viberti, Diabetologia 1993 36 993 997 10.1007/BF02374489 8243884
29. Effects of storage time and temperature on measurement of small concentrations of albumin in urine. I Osberg HP Chase SK Garg A DeAndrea S Harris R Hamilton G Marshall, Clin Chem 1990 36 1428 1430 2387037
30. Studies of diabetic nephropathy. I. Effects of storage time and temperature on microalbuminuria. F Hara K Nakazato K Shiba J Shimoda T Kojima Y Fukumura I Kobayashi, Biol Pharm Bull 1994 17 1241 1245 7841946
31. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. P Hovind L Tarnow K Rossing P Rossing S Eising N Larsen C Binder HH Parving, Diabetes Care 2003 26 1258 1264 12663607
32. Discordant trends in microvascular complications in adolescents with type 1 diabetes from 1990 to 2002. F Mohsin ME Craig J Cusumano AK Chan S Hing JW Lee M Silink NJ Howard KC Donaghue, Diabetes Care 2005 28 1974 1980 16043741
33. Etiology and prognostic significance of albuminuria in diabetes. G Viberti, Diabetes Care 1988 11 840 845 3073075
34. Microalbuminuria in type I diabetic patients. Prevalence and clinical characteristics. Microalbuminuria Collaborative Study Group. Diabetes Care 1992 15 495 501 1499464
35. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. A Schmitz M Vaeth, Diabet Med 1988 5 126 134 2964977
36. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. MA Gall P Hougaard K Borch-Johnsen HH Parving, Bmj 1997 314 783 788 9080995
37. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Bmj 1998 317 703 713 9732337
38. The relationship between glucose control and the development and progression of diabetic nephropathy. CA Phillips ME Molitch, Curr Diab Rep 2002 2 523 529 12643159
39. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. Kidney Int 1995 47 1703 1720 7643540
40. Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus. M Wiseman G Viberti D Mackintosh RJ Jarrett H Keen, Diabetologia 1984 26 401 405 10.1007/BF00262209 6468790
41. Microalbuminuria and hypertension with focus on type 1 and type 2 diabetes. CE Mogensen, J Intern Med 2003 254 45 66 10.1046/j.1365-2796.2003. 01157.x 12823642
42. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM. A Schmitz M Vaeth CE Mogensen, Diabetologia 1994 37 1251 1258 7895955
43. UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia. Diabetologia 1993 36 1021 1029 10.1007/BF02374494 8243850